Sunday, May 19, 2013
Sunday, May 19, 2013

Chat transcript: Making sense of prostate cancer screening

Last month, an influential federal panel rejected use of the PSA test as a screen for prostate cancer. A family physician will help sort through the confusion.

0 comments

Chat transcript: Making sense of prostate cancer screening

POSTED: Monday, June 11, 2012, 12:11 PM

Editor's Note: Scroll down to see the chat. 

Last month, in a controversial move, an influential federal panel rejected use of the PSA (prostate-specific antigen) test as a screen for prostate cancer. 

"At best, PSA screening may help only 1 man in 1,000 avoid death from prostate cancer," the U.S. Preventive Services Task Force said. "Most prostate cancers found by PSA screening are slow growing, not life threatening, and will not cause a man any harm during his lifetime."

Urologists and advocacy groups immediately decried the advice - as they did when a draft version was released last October - and worried that insurers may stop paying for PSA testing.

What should men do as they approach the age for such screening? 

Mona Sarfaty, M.D., an assistant professor in the Department of the Health Policy and the Department of Family and Community Medicine at Thomas Jefferson University, was online on June 14 at 1 p.m. to help readers sort through the confusion.

Sarfaty's current research focuses on policy initiatives in cancer prevention and control, and outcomes improvement in primary care. She is a certified family physician.

You can read the transcript from the chat below. 


0 comments
Comments  (0)


About this blog

Check Up is your guide to health and medicine across the Philadelphia region.

Brought to you by Philly.com/health and the Philadelphia Inquirer's Health and Science team, this blog covers major health events in our region and offers everything from personal health advice to an expert look at health reform.

Our guest bloggers include:

Reach Check at Checkup@philly.com.

Blog archives:
Past Archives: